semaglutide future Semaglutide. Tirzepatide. The names dominate headlines: “Game-changing weight loss injections.” “A revolution in diabetes care.” But beyond the buzz, here's what the evidence says: Glycemic control: Landmark trials (SURPASS, SUSTAIN) show significant Semaglutide for Weight Loss -

The panel also discussed that treatment of dermatitis with IL-17 and IL-23 inhibitors, and how technically these treatments may be beneficial for those with lichen planus

Neuroscience and Appetite Regulation Research Cagrilintide's selective action on brainstem satiety circuits provides insights into neural control of feeding behavior [14] : Central Nervous System Research Applications Area postrema neural activity mapping during amylin receptor activation Nucleus tractus solitarius (NTS) connectivity and second-order satiety neuron activation Integration of peripheral satiety signals (amylin, GLP-1, PYY, leptin) in feeding circuits Neuroplasticity changes in satiety pathways with chronic amylin agonist exposure [17] 6

Here we highlight the major risk factors: Patent Expiration (Cliff) Risk Pfizer faces a significant patent cliff between 2025 and 2030

Niosomal gel for site-specific sustained delivery of anti-arthritic drug: in vitro-in vivo evaluation

Yet patient access and engagement are sputtering